C. Abeygunawardana

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older

Meihua Wang, M. Kohn, Temitope A Folaranmi, 2021, Human vaccines & immunotherapeutics.

A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

R. Rupp, M. Winters, L. Musey, 2019, Human vaccines & immunotherapeutics.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age.

D. Greenberg, R. Rupp, J. Stek, 2018, Vaccine.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.

D. Greenberg, T. Vesikari, B. Coller, 2018, Vaccine.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

C. Acosta, A. Pedley, James T Peterson, 2019, Human vaccines & immunotherapeutics.

Immunogenicity Comparison of a Next Generation Pneumococcal Conjugate Vaccine in Animal Models and Human Infants.

Lani Indrawati, Julie M. Skinner, M. Winters, 2019, The Pediatric infectious disease journal.